Bayesian phase I/II adaptively randomized oncology trials with combined drugs

Annals of Applied Statistics

Volumn 5, Issue 2 A, 2011, Pages 924-942

  Yuan, Ying ^a,b   Yin, Guosheng ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adaptive randomization; Dose finding; Drug combination

Indexed keywords

EID: 84873378000     PISSN: 19326157     EISSN: 19417330     Source Type: Journal    
DOI: 10.1214/10-aoas433     Document Type: Article

References (26)

1. Clayton, D. G. (1978). A model for association in bivariate life tables and its application in epidemiological studies of familial tendency in chronic disease incidence. Biometrika 65 141-152.Mathematical Reviews (MathSciNet): MR501698 Zentralblatt MATH: 0394.92021 Digital Object Identifier: doi:10.1093/biomet/65.1.141
2. Conaway, M. R., Dunbar, S. and Peddada, S. D. (2004). Designs for single- or multiple-agent phase I trials. Biometrics 60 661-669.Mathematical Reviews (MathSciNet): MR2089441 Digital Object Identifier: doi:10.1111/j.0006-341X.2004.00215.x
3. Genest, C. and Rivest, L.-P. (1993). Statistical inference procedures for bivariate Archimedean copula. J. Amer. Statist. Assoc. 88 1034-1043.Mathematical Reviews (MathSciNet): MR1242947 Zentralblatt MATH: 0785.62032 Digital Object Identifier: doi:10.1080/01621459.1993.10476372
4. Gilks, W. R., Best, N. G. and Tan, K. K. C. (1995). Adaptive rejection Metropolis sampling. Appl. Statist. 44 455-472.
5. Gooley, T. A., Martin, P. J., Fisher, L. D. and Pettinger, M. (1994). Simulation as a design tool for phase I/II clinical trial: An example from bone marrow transplantation. Controlled Clinical Trial 15 450-462.
6. Hougaard, P. (1986). A class of multivariate failure time distribution. Biometrika 73 671-678.Mathematical Reviews (MathSciNet): MR897858 Zentralblatt MATH: 0613.62121
7. Huang, X., Biswas, S., Oki, Y., Issa, J.-P. and Berry, D. A. (2007). A parallel phase I/II clinical trial design for combination therapies. Biometrics 63 429-436.Mathematical Reviews (MathSciNet): MR2370801 Digital Object Identifier: doi:10.1111/j.1541-0420.2006.00685.x
8. Jennison, C. and Turnbull, B. (2000). Group Sequential Methods With Applications to Clinical Trials. Chapman and Hall/CRC, London.Mathematical Reviews (MathSciNet): MR1710781 Zentralblatt MATH: 0934.62078
9. Karrison, T., Huo, D. and Chappell, R. (2003). Group sequential, response-adaptive designs for randomized clinical trials. Controlled Clinical Trials 24 506-522.
10. Kramar, A., Lebecq, A. and Candalh, E. (1999). Continual reassessment methods in phase I trials of the combination of two drugs in oncology. Stat. Med. 18 1849-1864.
11. Korn, E. L. and Simon, R. (1993). Using the tolerable-dose diagram in the design of phase I combination chemotherapy trials. Journal of Clinical Oncology 11 794-801.
12. Nelson, R. B. (2006). An Introduction to Copulas, 2nd ed. Springer, New York.Mathematical Reviews (MathSciNet): MR2197664
13. O'Quigley, J., Hughes, M. D. and Fenton, T. (2001). Dose-finding designs for HIV studies. Biometrics 57 1018-1029.Mathematical Reviews (MathSciNet): MR1973811 Digital Object Identifier: doi:10.1111/j.0006-341X.2001.01018.x
14. O'Quigley, J., Pepe, M. and Fisher, L. (1990). Continual reassessment method: A practical design for phase 1 clinical trials in cancer. Biometrics 46 33-48.Mathematical Reviews (MathSciNet): MR1059105 Digital Object Identifier: doi:10.2307/2531628
15. Rosenberger, W. F. and Lachin, J. M. (2002). Randomization in Clinical Trials: Theory and Practice. Wiley, New York.Mathematical Reviews (MathSciNet): MR1914364
16. Simon, R. and Korn, E. L. (1990). Selecting drug combination based on total equivalence dose (dose intensity). Journal of the National Cancer Institute 82 1469-1476.
17. Storer, B. E. (1989). Design and analysis of phase I clinical trials. Biometrics 45 925-937.Mathematical Reviews (MathSciNet): MR1029610 Digital Object Identifier: doi:10.2307/2531693
18. Thall, P. F. and Cook, J. (2004). Dose-finding based on toxicity-efficacy trade-offs. Biometrics 60 684-693.Mathematical Reviews (MathSciNet): MR2089444 Digital Object Identifier: doi:10.1111/j.0006-341X.2004.00218.x
19. Thall, P. F., Millikan, R. E., Müller, P. and Lee, S.-J. (2003). Dose-finding with two agents in phase I oncology trials. Biometrics 59 487-496.Mathematical Reviews (MathSciNet): MR2004253 Digital Object Identifier: doi:10.1111/1541-0420.00058
20. Thall, P. F. and Russell, K. E. (1998). A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials. Biometrics 54 251-264.
21. Wang, K. and Ivanova, A. (2005). Two-dimensional dose finding in discrete dose space. Biometrics 61 217-222.Mathematical Reviews (MathSciNet): MR2135863 Digital Object Identifier: doi:10.1111/j.0006-341X.2005.030540.x
22. Yin, G., Li, Y. and Ji, Y. (2006). Bayesian dose-finding in phase I/II trials using toxicity and efficacy odds ratio. Biometrics 62 777-784.Mathematical Reviews (MathSciNet): MR2247206 Digital Object Identifier: doi:10.1111/j.1541-0420.2006.00534.x
23. Yin, G. and Yuan, Y. (2009). Bayesian dose finding in oncology for drug combinations by copula regression. Appl. Statist. 58 211-224.Mathematical Reviews (MathSciNet): MR2649671 Digital Object Identifier: doi:10.1111/j.1467-9876.2009.00649.x
24. Yin, G. and Yuan, Y. (2010). Rejoinder to the discussion of "Bayesian dose finding in oncology for drug combinations by copula regression." Appl. Statist. 59 544-546.Mathematical Reviews (MathSciNet): MR2758315 Digital Object Identifier: doi:10.1111/j.1467-9876.2010.00710_2.x
25. Yuan, Z., Chappell, R. and Bailey, H. (2007). The continual reassessment method for multiple toxicity grades: A Bayesian quasi-likelihood approach. Biometrics 63 173-179.Mathematical Reviews (MathSciNet): MR2345586 Digital Object Identifier: doi:10.1111/j.1541-0420.2006.00666.x
26. Yuan, Y. and Yin, G. (2009). Bayesian dose-finding by jointly modeling toxicity and efficacy as time-to-event outcomes. Appl. Statist. 58 719-736.Mathematical Reviews (MathSciNet): MR2750264 Digital Object Identifier: doi:10.1111/j.1467-9876.2009.00674.x